BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29603582)

  • 1. miRNA-mediated 'tug-of-war' model reveals ceRNA propensity of genes in cancers.
    Swain AC; Mallick B
    Mol Oncol; 2018 Jun; 12(6):855-868. PubMed ID: 29603582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
    Chiu YC; Hsiao TH; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of computational methods for identifying miRNA-mediated RNA-RNA crosstalk.
    Li Y; Jin X; Wang Z; Li L; Chen H; Lin X; Yi S; Zhang Y; Xu J
    Brief Bioinform; 2019 Jul; 20(4):1193-1204. PubMed ID: 29077860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
    Do D; Bozdag S
    PLoS Comput Biol; 2018 Jul; 14(7):e1006318. PubMed ID: 30011266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
    Ergun S; Oztuzcu S
    Tumour Biol; 2015 May; 36(5):3129-36. PubMed ID: 25809705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ceRNA in cancer: possible functions and clinical implications.
    Qi X; Zhang DH; Wu N; Xiao JH; Wang X; Ma W
    J Med Genet; 2015 Oct; 52(10):710-8. PubMed ID: 26358722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PceRBase: a database of plant competing endogenous RNA.
    Yuan C; Meng X; Li X; Illing N; Ingle RA; Wang J; Chen M
    Nucleic Acids Res; 2017 Jan; 45(D1):D1009-D1014. PubMed ID: 28053167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.
    Cheng DL; Xiang YY; Ji LJ; Lu XJ
    Tumour Biol; 2015 Feb; 36(2):479-88. PubMed ID: 25604144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA inhibitors: Natural and artificial sequestration of microRNA.
    Tang L; Chen HY; Hao NB; Tang B; Guo H; Yong X; Dong H; Yang SM
    Cancer Lett; 2017 Oct; 407():139-147. PubMed ID: 28602827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic Modelling of Competition and Depletion of Shared miRNAs by Competing Endogenous RNAs.
    Martirosyan A; Del Giudice M; Bena CE; Pagnani A; Bosia C; De Martino A
    Methods Mol Biol; 2019; 1912():367-409. PubMed ID: 30635902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.
    Chiu YC; Wang LJ; Lu TP; Hsiao TH; Chuang EY; Chen Y
    BMC Bioinformatics; 2017 Feb; 18(1):132. PubMed ID: 28241741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational methods for identifying miRNA sponge interactions.
    Le TD; Zhang J; Liu L; Li J
    Brief Bioinform; 2017 Jul; 18(4):577-590. PubMed ID: 27273287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics.
    Sanchez-Mejias A; Tay Y
    J Hematol Oncol; 2015 Mar; 8():30. PubMed ID: 25888444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.
    Xu J; Li Y; Lu J; Pan T; Ding N; Wang Z; Shao T; Zhang J; Wang L; Li X
    Nucleic Acids Res; 2015 Sep; 43(17):8169-82. PubMed ID: 26304537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the microRNA pool and the factors affecting its regulatory potential.
    Cui K; Lyu Q; Xu N; Liu Q; Zhang J; Xing W; Bai L; Liao M; He J; Yuan B; Chen D; Xie W; Zhang Y
    Integr Biol (Camb); 2014 Dec; 6(12):1141-52. PubMed ID: 25222482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing endogenous RNA in cancer: a new pattern of gene expression regulation.
    Qu J; Li M; Zhong W; Hu C
    Int J Clin Exp Med; 2015; 8(10):17110-6. PubMed ID: 26770304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
    Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
    Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.